Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Start-Up Execs On The Move, February 2015

This article was originally published in Start Up

Executive Summary

Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.

Start-Up Execs

Arvinas Inc.

Manuel Litchman, MD

To:Pres. & CEO (January)

From:SVP & Global Program Head, Novartis Pharmaceuticals

Phone:203-535-1456

Augmenix Inc.

Ken Knudson

To:VP, Global Sales & Mktg. (January)

From:VP, Global Sales, Cheetah Medical Inc.

Phone:781-895-3235

John Pedersen

To:CEO (January)

From:Senior Healthcare Advisor, The Gores Group

Phone:781-895-3235

CytomX Therapeutics Inc.

W. Michael Kavanaugh, MD

To:CSO & Head, Research & Early Dev. (January)

From:SVP, CSO, Five Prime Therapeutics Inc.

Phone:650-515-3185

Euclises Pharmaceuticals Inc.

Bobby W. Sandage, Jr., PD

To:Pres. & CEO (January)

From:Pres. & CEO, Coronado Biosciences Inc.

Phone:314-690-1441

Jounce Therapeutics Inc.

Deborah Law, DPhil

To:CSO (January)

From:CSO, Ablynx NV

Phone:857-259-3840

Principia BioPharma Inc.

Roy Hardiman

To:CBO (January)

From:Co-owner & General Counsel, Woodlands Inc.

Phone:650-416-7700

Scioderm Inc.

Ian A. W. Howes

To:CFO (January)

From:CFO & VP, Corp. Dev., Akebia Therapeutics Inc.

Phone:919-328-2020

Seres Therapeutics Inc.

Michele (Shelly) Trucksis, MD, PhD

To:EVP, CMO (January)

From:Exec. Dir., Merck Research Laboratories

Phone:617-945-9626

Targovax AS

Anne-Kirsti Aksnes, PhD

To:VP, Clinical Dev. (January)

From:VP, Clinical Research, Algeta ASA

Phone:+47 6712 2658

Tina Madsen

To:VP, Quality Assurance (January)

From:Dir., Product Quality Assurance, Algeta ASA

Phone:+47 6712 2658

Tute Genonics Inc.

David Mittelman, PhD

To:CSO (January)

From:Co-founder, Arpeggi Inc.

Phone:858-779-4363

Andrew Olson

To:VP, Sales (December)

From:VP, Sales, Great Basin Corp.

Phone:858-779-4363

Unum Therapeutics Inc.

Christiana Stamoulis

To:CFO & Head, Corp. Dev. (January)

From:SVP & Head, Corp. Strategy & Bus. Dev., Vertex Pharmaceuticals Inc.

Phone:617-863-3679

Start-Up Directors

Alzheon Inc.

David Nikodem, PhD

To:Director (January)

Phone:857-214-7242

Batu Biologics Inc.

Alan Lewis, PhD

To:Chairman (January)

Phone:213-359-3179

Global Blood Therapeutics Inc.

Willie L. Brown, Jr.

To:Director (January)

Phone:650-741-7700

Principia BioPharma Inc.

Lewis Shuster

To:Director (January)

Phone:650-416-7700

Scioderm Inc.

Mike Lee

To:Director (December)

Phone:919-328-2020

Start-Up Investors

Piper Jaffray

Matthew O'Brien

To:Principal & Senior Research Analyst (December)

From:Senior Analyst, William Blair & Co. LLC

Phone:800-333-6000

Sofinnova Ventures

Daniel G. Welch

To:Exec. Partner (January)

From:Chmn., Pres. & CEO, InterMune Inc.

Phone:650-681-8420

Wake Forest Innovations

Jeff Brennan

To:VP, Industry Relations & Bus. Dev. (January)

From:SVP, Bus. & Commercial Dev. & CBO, Targacept Inc.

Phone:336-716-8508

Start-Up Advisors

Alcyone Lifesciences Inc.

Michael Rogawski, MD, PhD

To:Clinical & Scientific Advisor (December)

Phone:978-709-1946

Neurotrope Inc.

Jeffrey L. Cummings, MD

To:Alzheimer's Disease Clinical Advisor (January)

Phone:945-632-6630

Martin R. Farlow, MD

To:Alzheimer's Disease Clinical Advisor (January)

Phone:945-632-6630

Sam Gandy, MD, PhD

To:Alzheimer's Disease Clinical Advisor (January)

Phone:945-632-6630

Christina Sampaio, MD, PhD

To:Alzheimer's Disease Clinical Advisor (January)

Phone:945-632-6630

Michael Weiner, MD

To:Alzheimer's Disease Clinical Advisor (January)

Phone:945-632-6630

Raze Therapeutics

Julian Adams, PhD

To:Scientific Advisor (January)

Phone:617-588-2600

George Q. Daley, MD, PhD

To:Scientific Advisor (January)

Phone:617-588-2600

Karen Vousden, PhD

To:Scientific Advisor (January)

Phone:617-588-2600

Promotions

Sprout Pharmaceuticals Inc.

Cindy Whitehead

To:CEO (January)

From:Pres. & COO

Phone:918-882-0850

Resignations

Promethera Biosciences SA NV

Eric Halioua

From:CEO (January)

Phone:+32 10 39 43 00

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC092716

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel